Cannabix Technologies Inc
CNSX:BLO
Intrinsic Value
Cannabix Technologies, Inc. engages in the development and manufacturing of marijuana breathalyzer for law enforcement. [ Read More ]
The intrinsic value of one BLO stock under the Base Case scenario is 0.06 CAD. Compared to the current market price of 0.46 CAD, Cannabix Technologies Inc is Overvalued by 88%.
Valuation Backtest
Cannabix Technologies Inc
Run backtest to discover the historical profit from buying and selling BLO stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Cannabix Technologies Inc
Current Assets | 5.1m |
Cash & Short-Term Investments | 5m |
Receivables | 40k |
Other Current Assets | 53.8k |
Non-Current Assets | 276.9k |
PP&E | 230.9k |
Other Non-Current Assets | 46k |
Current Liabilities | 107k |
Accounts Payable | 62.6k |
Other Current Liabilities | 44.4k |
Earnings Waterfall
Cannabix Technologies Inc
Revenue
|
0
CAD
|
Operating Expenses
|
-1.5m
CAD
|
Operating Income
|
-1.5m
CAD
|
Other Expenses
|
106.3k
CAD
|
Net Income
|
-1.4m
CAD
|
Free Cash Flow Analysis
Cannabix Technologies Inc
BLO Profitability Score
Profitability Due Diligence
Cannabix Technologies Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
Score
Cannabix Technologies Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
BLO Solvency Score
Solvency Due Diligence
Cannabix Technologies Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Cannabix Technologies Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BLO Price Targets Summary
Cannabix Technologies Inc
Shareholder Return
BLO Price
Cannabix Technologies Inc
Average Annual Return | -6.1% |
Standard Deviation of Annual Returns | 79.02% |
Max Drawdown | -100% |
Market Capitalization | 52.5m CAD |
Shares Outstanding | 114 144 104 |
Percentage of Shares Shorted | 0.01% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Cannabix Technologies, Inc. engages in the development and manufacturing of marijuana breathalyzer for law enforcement. The company is headquartered in Burnaby, British Columbia. The company went IPO on 2013-12-16. The firm is engaged in developing breath testing technologies that can be used at the point of care to detect recent use of marijuana. The company is using a field asymmetric ion mobility spectrometry (FAIMS) technology to detect 9-tetrahydrocannabinol (THC), a non-volatile compound, in breath. Its FAIMS device is designed to operate both independently and coupled in tandem directly to a mass spectrometer (MS), used in forensic labs. Its THC Breath Analyzer (THCBA) is a point of care breath testing tool for the rapid detection of recent cannabis use. THCBA collects a single breath from the user and the sensor response is represented by a characteristic pattern or smell-print to the specific target gas. The THCBA has been built to provide easy to understand screen prompts for the positive and negative detection of THC in breath in a portable manner.
Contact
IPO
Employees
Officers
The intrinsic value of one BLO stock under the Base Case scenario is 0.06 CAD.
Compared to the current market price of 0.46 CAD, Cannabix Technologies Inc is Overvalued by 88%.